1-2 of 2
David Tougeron
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

Subject Area:
Endocrinology , Neurology and Neuroscience
Louis de Mestier, Thomas Walter, Camille Evrard, Paul de Boissieu, Olivia Hentic, Jérôme Cros, David Tougeron, Catherine Lombard-Bohas, Vinciane Rebours, Pascal Hammel, Philippe Ruszniewski
Journal: Neuroendocrinology
Neuroendocrinology (2020) 110 (1-2): 83–91.
https://doi.org/10.1159/000500862
Published Online: 10 May 2019
View article titled, Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor
Open the PDF for Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor in another window
Journal Articles

Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses

Subject Area:
Endocrinology , Neurology and Neuroscience
Louis de Mestier, Thomas Walter, Hedia Brixi, Camille Evrard, Jean-Louis Legoux, Paul de Boissieu, Olivia Hentic, Jérôme Cros, Pascal Hammel, David Tougeron, Catherine Lombard-Bohas, Vinciane Rebours, Philippe Ruszniewski, Guillaume Cadiot
Journal: Neuroendocrinology
Neuroendocrinology (2019) 108 (4): 343–353.
https://doi.org/10.1159/000498887
Published Online: 13 February 2019
View article titled, Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses
Open the PDF for Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses in another window